ni Lolet Abania | March 18, 2021
Binigyan na ng emergency use authorization (EUA) ng Pilipinas ang Sputnik V COVID-19 vaccine ng Russia.
Sa late stage trial results, napag-alamang 91.6% effective ang Sputnik V, ayon kay Food and Drug Administration (FDA) Director-General Eric Domingo.
Saad pa ni Domingo, "Based on the totality of evidence available to date, including data from adequate and well-known controlled trials, it is reasonable to believe that the Gamaleya National Center of Epidemiology and Microbiology Sputnik V Gam-Cov-Vac COVID-19 vaccine may be effective to prevent COVID-19.”
Aniya pa, "The adverse events reported were mostly mild and transient, similar to common vaccine reactions. No specific safety concerns were identified.”
Samantala, aabot sa 3 million doses ng Sputnik V COVID-19 vaccine ang inorder ng Pilipinas matapos itong mabigyan ng EUA, ayon kay Vaccine Czar Secretary Carlito Galvez, Jr. ngayong Biyernes.
Saad ni Galvez, “We will have a meeting this coming Tuesday. And our initial request is for them to deliver more or less three million doses this coming April [and] May.
“We also have an ongoing negotiation with them to allow LGUs (local government units) to buy the vaccine.” Ang Sputnik V ay two-dose vaccine matapos ang tatlong linggo at ang mga edad 18 pataas lamang ang maaaring mabakunahan nito.
Comments